Loading...
XWAR
SNT
Market cap635mUSD
Dec 05, Last price  
273.00PLN
1D
0.89%
1Q
12.62%
Jan 2017
1,628.94%
IPO
3,257.93%
Name

Synektik SA

Chart & Performance

D1W1MN
XWAR:SNT chart
P/E
27.51
P/S
3.73
EPS
9.92
Div Yield, %
1.12%
Shrs. gr., 5y
Rev. gr., 5y
35.87%
Revenues
624m
+39.66%
31,026,57145,077,18261,451,51277,375,82778,693,40683,598,41749,433,13662,936,490105,323,138134,786,623125,386,200128,627,450166,860,941446,871,567624,121,793
Net income
85m
+61.36%
1,063,660008,244,2983,604,8050388,0914,085,13010,293,4369,136,2958,810,1348,383,81010,301,20652,452,19084,636,220
CFO
90m
-5.17%
07,150,8912,666,7686,431,59211,962,2635,722,563014,571,6405,224,43813,547,20313,927,83821,710,302094,493,46389,609,373
Dividend
Mar 01, 20243.03 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine; the development of IT solutions used in radiology; and produces and sells radiopharmaceutical products used in diagnostics for oncology. It also operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. In addition, the company offers maintenance services for medical equipment, as well as acceptance and specialist tests. Synektik Spólka Akcyjna was founded in 2001 and is based in Warsaw, Poland.
IPO date
Aug 09, 2011
Employees
151
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT